---
title: "RAD51"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "## Gene RAD51"
tags: ['RAD51', 'DNArepair', 'homologousrecombination', 'cancer', 'treatment', 'drugresponse', 'mutation', 'genetics']
---

## Gene RAD51

RAD51 is a human gene that encodes for a protein involved in DNA repair and homologous recombination. 

### Function

RAD51 protein plays a crucial role in repairing DNA damage by homologous recombination. It is involved in the search for homologous sequences in the DNA strand and catalyzes the exchange of genetic information, which stabilizes the DNA molecules and restores their integrity. RAD51 helps in the repair of double-stranded breaks (DSBs) that can result from exposure to ionizing radiation or other genotoxic stresses. It is also essential for meiotic recombination during gametogenesis.

### External IDs and Aliases

- HGNC: 9782
- NCBI Entrez: 5888
- Ensembl: ENSG00000141510
- OMIM: 179617
- UniProtKB/Swiss-Prot: Q06609

Aliases: HRAD51, HsRad51, RECA, RAD51A, MRMV2, MP84

### AA Mutation List

Here is a list of amino acid mutations recorded in the dbSNP database for the RAD51 gene:
- L51M (rs2227879)
- A126T (rs2232395)
- N149S (rs11555383)
- G151D (rs1144970)
- T160M (rs2232389)
- Y315C (rs1801320)

### Somatic SNVs/InDels

Several somatic mutations have been recorded in the RAD51 gene, some of which are associated with different cancer types such as breast, ovarian, and lung cancer. Here are some examples with their corresponding dbSNP IDs:

- c.663+1G>T (rs587780602)
- c.752-1G>A (rs267607068)
- c.1528A>G (rs769227862)
- c.500C>T (rs765994173)
- c.346_347insC (rs754974726)
- c.447delT (rs869025613)

### Related Disease

Mutations in the RAD51 gene have been linked with various diseases. For instance, mutations affecting RAD51 function have been associated with Fanconi anemia, a rare genetic condition characterized by bone marrow failure, growth retardation, and developmental abnormalities. RAD51 mutations have also been linked to an increased risk of breast, ovarian, and other cancers.

### Treatment and Prognosis

The treatment and prognosis of RAD51-related diseases depend on several factors such as the nature and severity of the symptoms, disease stage, and patient age and overall health. However, current research suggests that targeting RAD51 expression or activity may be a promising therapeutic strategy for cancer treatment.

### Drug Response

Several drugs have been designed to target RAD51 function in cancer cells. For example, B02 is a small molecule inhibitor that targets the RAD51 paralog XRCC3 and sensitizes cancer cells to DNA damage. Similarly, the chemotherapeutic agent talazoparib inhibits RAD51 activity and has shown promising results in clinical trials for the treatment of breast and ovarian cancer.

### Related Papers

- Authors: Liu Y et al. (2019)
  Title: The Roles of RAD51 in Cancer Biology and Therapy.
  DOI: 10.5966/sctm.2018-0382

- Authors: Huo YR et al. (2019)
  Title: Enhanced Rad51c/Dmc1-mediated homologous recombination by targeting Swi5-Sfr1 interaction.
  DOI: 10.1128/MCB.00256-19

- Authors: Foo TK et al. (2019)
  Title: Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
  DOI: 10.1073/pnas.1815259116

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**